|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
| 1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Incentive Stock Option (right to buy) | $ 1 | 03/05/2013 | A | 161,112 | 04/05/2013(1) | 03/05/2023 | Common Stock | 161,112 | $ 0 | 161,112 | D | ||||
| Non-Qualified Stock Option (right to buy) | $ 1 | 03/05/2013 | A | 138,888 | 04/05/2013(1) | 03/05/2023 | Common Stock | 138,888 | $ 0 | 138,888 | D | ||||
| Incentive Stock Option (right to buy) | $ 1.05 | 04/05/2012(2) | 03/05/2022 | Common Stock | 136,434 | 136,434 | D | ||||||||
| Incentive Stock Option (right to buy) | $ 1.57 | 03/31/2011(3) | 02/28/2021 | Common Stock | 71,298 | 71,298 | D | ||||||||
| Incentive Stock Option (right to buy) | $ 1.85 | 03/26/2009(4) | 02/26/2019 | Common Stock | 31,669 | 31,669 | D | ||||||||
| Incentive Stock Option (right to buy) | $ 3.08 | 03/24/2010(5) | 02/24/2020 | Common Stock | 44,954 | 44,954 | D | ||||||||
| Incentive Stock Option (right to buy) | $ 3.37 | 03/29/2008(6) | 02/28/2018 | Common Stock | 10,395 | 10,395 | D | ||||||||
| Incentive Stock Option (right to buy) | $ 6.5 | 03/01/2004(7) | 03/04/2014 | Common Stock | 12,500 | 12,500 | D | ||||||||
| Incentive Stock Option (right to buy) | $ 6.81 | 04/01/2007(8) | 03/14/2017 | Common Stock | 17,722 | 17,722 | D | ||||||||
| Incentive Stock Option (right to buy) | $ 7.04 | 04/01/2006(9) | 03/15/2016 | Common Stock | 35,000 | 35,000 | D | ||||||||
| Incentive Stock Option (right to buy) | $ 7.1 | 04/01/2005(10) | 03/23/2015 | Common Stock | 9,000 | 9,000 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $ 1.05 | 04/05/2012(2) | 03/05/2022 | Common Stock | 38,566 | 38,566 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $ 1.57 | 03/31/2011(3) | 02/28/2021 | Common Stock | 3,702 | 3,702 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $ 1.85 | 03/26/2009(4) | 02/26/2019 | Common Stock | 8,331 | 8,331 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $ 3.08 | 03/24/2010(5) | 02/24/2020 | Common Stock | 5,046 | 5,046 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $ 3.37 | 03/29/2008(6) | 02/28/2018 | Common Stock | 8,415 | 8,415 | D | ||||||||
| Non-Qualified Stock Option (right to buy) | $ 6.81 | 04/01/2007(8) | 03/14/2017 | Common Stock | 2,078 | 2,078 | D | ||||||||
| Restricted Stock Units | (11) | (12) | (12) | Common Stock | 87,500 | 87,500 | D | ||||||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
| Malik Fady Ibraham 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO, CA 94080 |
SVP Research & Early Dev | |||
| Fady Malik, M.D., Ph.D. | 03/07/2013 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | When the ISO and NQ dated 03/05/2013 are combined for a total grant of 300,000 shares, the option shall vest and become exercisable as to 300,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/05/2017. |
| (2) | When the ISO and NQ dated 03/05/2012 are combined for a total grant of 175,000 shares, the option shall vest and become exercisable as to 3,645 shares on 04/05/2012 and the balance of 171,355 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/05/2016. |
| (3) | When the ISO and NQ dated 02/28/2011 are combined for a total grant of 75,000 shares, the option shall vest and become exercisable as to 1,562 shares on 03/31/2011 and the balance of 73,438 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/28/2015. |
| (4) | When the ISO and NQ dated 02/26/2009 are combined for a total grant of 40,000 shares, the option shall vest and become exercisable as to 833 shares on 03/26/09 and the balance of 39,167 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/13. |
| (5) | When the ISO and NQ dated 02/24/2010 are combined for a total grant of 50,000 shares, the option shall vest and become exercisable as to 1,041 shares on 03/24/2010 and the balance of 48,959 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/24/2014. |
| (6) | When the ISO and NQ dated 02/29/2008 are combined for a total grant of 18,810 shares, the option shall vest and become exercisable as to 391 shares on 03/29/08 and the balance of 18,419 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/29/12. |
| (7) | This option is immediately exercisable upon grant and shall vest as to 260 shares on 04/01/04 and the balance of 12,240 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/08. |
| (8) | When the ISO and NQ dated 03/14/2007 are combined for a total grant of 19,800 shares, the option shall vest and become exercisable as to 412 shares on 04/01/07 and the balance of 19,388 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11. |
| (9) | This option shall vest and become exercisable as to 729 shares on 04/01/06 and the balance of 34,271 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/10. |
| (10) | This option shall vest and become exercisable as to 187 shares on 04/01/05 and the balance of 8,813 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/09. |
| (11) | Each restricted stock unit represents a contingent right to receive one share of CYTK common stock at a purchase price of $0.001 per share which is the current par value of the common stock. |
| (12) | The restricted stock units vest in two equal annual installments. Vested shares will be delivered to the reporting person on 9/4/2012 and 9/3/2013. |